CIAM
COYA icon

Caitong International Asset Management’s Coya Therapeutics COYA Stock Holding History

Caitong International Asset Management’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12 Buy
+3
New +$14 ﹤0.01% 2121

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Caitong International Asset Management's COYA Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Coya Therapeutics (COYA) in Q1 2026: 3 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #2121 among its holdings.

56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Caitong International Asset Management held 3 shares of Coya Therapeutics worth $12 as of Q1 2026.
  • Coya Therapeutics was a new Caitong International Asset Management position in Q1 2026.
  • Coya Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2121 holding.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.